<?xml version="1.0" encoding="UTF-8"?>
<ref id="hep41480-bib-0050">
 <label>50</label>
 <mixed-citation publication-type="journal" id="hep41480-cit-0050">
  <string-name>
   <surname>Marcellin</surname>
   <given-names>P</given-names>
  </string-name>, 
  <string-name>
   <surname>Gane</surname>
   <given-names>E</given-names>
  </string-name>, 
  <string-name>
   <surname>Flisiak</surname>
   <given-names>R</given-names>
  </string-name>, 
  <string-name>
   <surname>Trinh</surname>
   <given-names>H</given-names>
  </string-name>, 
  <string-name>
   <surname>Petersen</surname>
   <given-names>J</given-names>
  </string-name>, 
  <string-name>
   <surname>Gurel</surname>
   <given-names>S</given-names>
  </string-name>, et al. 
  <article-title>Long term treatment with tenofovir disoproxil fumarate for chronic hepatitis B infection is safe and well tolerated and associated with durable virologic response with no detectable resistance: 8 year results from two phase 3 trials</article-title> [Abstract]. 
  <source xml:lang="en">Hepatology</source>
  <year>2014</year>;
  <volume>60</volume>(Suppl. 
  <issue>1</issue>):
  <fpage>313A</fpage>.
 </mixed-citation>
</ref>
